The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans

Brian S. Finlin(University of Kentucky), Philip A. Kern(University of Kentucky)
Journal of Clinical Investigation
January 21, 2020
Cited by 255


Related Papers